Project Grant K43TW012839
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$110K
Federal Agency
Fogarty International Center
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Uganda
Similar Awards
This Project Grant award from the National Institutes of Health's John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to develop and assess the feasibility of a diagnostic tool for post-tuberculosis (TB) lung disease that can be deployed in Ugandan primary healthcare settings with limited access to specialized diagnostics. The $108,237 award to Mbarara University of Science and Technology (MUST) in Uganda will fund three main activities: (1)...
This $134,811 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to identify and adapt an intervention to address common mental disorders (CMDs) among people being treated for tuberculosis (TB) in Uganda. The key objectives are to: 1) examine the relationship between CMDs and TB treatment adherence/outcomes to identify critical timing and type of intervention needed, 2) adapt and explore...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a 16-site cluster-randomized trial in Uganda to evaluate the impact of a peer-led navigation strategy on improving tuberculosis (TB) and HIV treatment adherence and outcomes. The $646,561 award will support the development and implementation of a multi-component peer-navigation intervention that includes task-shifting TB education and...
This Project Grant award from the Fogarty International Center (CFDA 93.989) at the National Institutes of Health will provide $559,341 over 5 years to support a research project on tuberculosis (TB) in children under 5 years old in Malawi. The primary awardee is a collaborative research partnership between Henry Ford Health and Michigan State University Health Sciences. The key objectives of the research project are to: 1) evaluate the accuracy of new non-invasive TB diagnostic strategies using...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) totals $1,251,718 and will be executed from September 2024 through June 2029. The primary objectives are to: Determine the impact of HIV co-infection on cardiopulmonary function in individuals who have completed treatment for pulmonary tuberculosis (TB), including assessments of pulmonary function tests, echocardiography, 6-minute walk test,...
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $749,200.00 in funding to the Regents of the University of Minnesota to establish the Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium in Uganda. The program aims to expand research expertise and build capacity in Uganda related to neuro-infectious diseases, particularly HIV-related cryptococcal meningitis and TB meningitis. The...
This Project Grant award of $335,559.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund a pilot feasibility study to assess the impact of a Focal Mass Drug Administration (FMDA) program for reducing malaria in pregnancy (MIP) in rural Western Uganda. The study aims to determine the feasibility, acceptability, and preliminary effectiveness of providing FMDA with dihydroartemisinin-piperaquine...
This $196,881 Project Grant award under the Trans-NIH Research Support program (CFDA 93.310) from the National Institutes of Health (NIH) Office of the Director will fund research to adapt an existing alcohol use intervention, called KISOBOKA, for use with men living with HIV (MLWH) who have serodiscordant pregnant partners in Uganda. The goals are to engage stakeholders to co-adapt the intervention, refine it through theater testing and feedback, and conduct a pilot randomized controlled trial....
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $108,916 to the Kamuzu University of Health Sciences in Malawi to characterize the pharmacokinetic and safety profiles of the antimalarial drugs artemether-lumefantrine and amodiaquine in two key target populations: children with severe acute malnutrition and adults living with HIV on dolutegravir-based antiretroviral therapy. The goal is to inform optimal dosing...
This $134,340 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Socios En Salud Sucursal Peru, a non-profit healthcare organization in Peru. The grant funds a study to assess the safety, tolerability, effectiveness, and pharmacodynamics of a 6-month levofloxacin-based regimen for treating isoniazid-resistant tuberculosis (TB). The study will recruit 218 participants in Peru to...